Literature DB >> 33571174

COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination - United States, September and December 2020.

Kimberly H Nguyen, Anup Srivastav, Hilda Razzaghi, Walter Williams, Megan C Lindley, Cynthia Jorgensen, Neetu Abad, James A Singleton.   

Abstract

As of February 8, 2021, 59.3 million doses of vaccines to prevent coronavirus disease 2019 (COVID-19) had been distributed in the United States, and 31.6 million persons had received at least 1 dose of the COVID-19 vaccine (1). However, national polls conducted before vaccine distribution began suggested that many persons were hesitant to receive COVID-19 vaccination (2). To examine perceptions toward COVID-19 vaccine and intentions to be vaccinated, in September and December 2020, CDC conducted household panel surveys among a representative sample of U.S. adults. From September to December, vaccination intent (defined as being absolutely certain or very likely to be vaccinated) increased overall (from 39.4% to 49.1%); the largest increase occurred among adults aged ≥65 years. If defined as being absolutely certain, very likely, or somewhat likely to be vaccinated, vaccination intent increased overall from September (61.9%) to December (68.0%). Vaccination nonintent (defined as not intending to receive a COVID-19 vaccination) decreased among all adults (from 38.1% to 32.1%) and among most sociodemographic groups. Younger adults, women, non-Hispanic Black (Black) persons, adults living in nonmetropolitan areas, and adults with lower educational attainment, with lower income, and without health insurance were most likely to report lack of intent to receive COVID-19 vaccine. Intent to receive COVID-19 vaccine increased among adults aged ≥65 years by 17.1 percentage points (from 49.1% to 66.2%), among essential workers by 8.8 points (from 37.1% to 45.9%), and among adults aged 18-64 years with underlying medical conditions by 5.3 points (from 36.5% to 41.8%). Although confidence in COVID-19 vaccines increased during September-December 2020 in the United States, additional efforts to tailor messages and implement strategies to further increase the public's confidence, overall and within specific subpopulations, are needed. Ensuring high and equitable vaccination coverage across all populations is important to prevent the spread of COVID-19 and mitigate the impact of the pandemic.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33571174      PMCID: PMC7877585          DOI: 10.15585/mmwr.mm7006e3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

1.  National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.

Authors:  Peter G Szilagyi; Kyla Thomas; Megha D Shah; Nathalie Vizueta; Yan Cui; Sitaram Vangala; Arie Kapteyn
Journal:  JAMA       Date:  2020-12-29       Impact factor: 56.272

2.  Determinants of COVID-19 vaccine acceptance in the US.

Authors:  Amyn A Malik; SarahAnn M McFadden; Jad Elharake; Saad B Omer
Journal:  EClinicalMedicine       Date:  2020-08-12

3.  Characteristics of Persons Who Died with COVID-19 - United States, February 12-May 18, 2020.

Authors:  Jonathan M Wortham; James T Lee; Sandy Althomsons; Julia Latash; Alexander Davidson; Kevin Guerra; Kenya Murray; Emily McGibbon; Carolina Pichardo; Brian Toro; Lan Li; Marc Paladini; Meredith L Eddy; Kathleen H Reilly; Lisa McHugh; Deepam Thomas; Stella Tsai; Mojisola Ojo; Samantha Rolland; Maya Bhat; Katherine Hutchinson; Jennifer Sabel; Seth Eckel; Jim Collins; Catherine Donovan; Anna Cope; Breanna Kawasaki; Sarah McLafferty; Nisha Alden; Rachel Herlihy; Bree Barbeau; Angela C Dunn; Charles Clark; Pamela Pontones; Meagan L McLafferty; Dean E Sidelinger; Anna Krueger; Leslie Kollmann; Linnea Larson; Stacy Holzbauer; Ruth Lynfield; Ryan Westergaard; Richard Crawford; Lin Zhao; Jonathan M Bressler; Jennifer S Read; John Dunn; Adele Lewis; Gillian Richardson; Julie Hand; Theresa Sokol; Susan H Adkins; Brooke Leitgeb; Talia Pindyck; Taniece Eure; Karen Wong; Deblina Datta; Grace D Appiah; Jessica Brown; Rita Traxler; Emilia H Koumans; Sarah Reagan-Steiner
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-07-17       Impact factor: 17.586

4.  The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020.

Authors:  Kathleen Dooling; Mona Marin; Megan Wallace; Nancy McClung; Mary Chamberland; Grace M Lee; H Keipp Talbot; José R Romero; Beth P Bell; Sara E Oliver
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-01       Impact factor: 35.301

5.  The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.

Authors:  Kathleen Dooling; Nancy McClung; Mary Chamberland; Mona Marin; Megan Wallace; Beth P Bell; Grace M Lee; H Keipp Talbot; José R Romero; Sara E Oliver
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-12-11       Impact factor: 17.586

  5 in total
  82 in total

1.  Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China.

Authors:  Jiahao Wang; Beibei Yuan; Xinran Lu; Xiaoxue Liu; Li Li; Shufan Geng; Haijun Zhang; Xiaozhen Lai; Yun Lyu; Huangyufei Feng; Rize Jing; Jia Guo; Yingzhe Huang; Xun Liang; Wenzhou Yu; Hai Fang
Journal:  Hum Vaccin Immunother       Date:  2021-12-14       Impact factor: 3.452

2.  Measuring vaccination willingness in response to COVID-19 using a multi-criteria-decision making method.

Authors:  Adnan Sarwar; Naima Nazar; Nimra Nazar; Alia Qadir
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

3.  Factors influencing intent to receive COVID-19 vaccination among Black and White adults in the southeastern United States, October - December 2020.

Authors:  Jennifer Cunningham-Erves; Carol S Mayer; Xijing Han; Landon Fike; Chang Yu; Phyllis M Tousey; David G Schlundt; Deepak K Gupta; Michael T Mumma; David Walkley; Mark D Steinwandel; Kathryn M Edwards; Loren Lipworth; Maureen Sanderson; Xiao-Ou Shu; Martha J Shrubsole
Journal:  Hum Vaccin Immunother       Date:  2021-11-30       Impact factor: 3.452

4.  Perceptions and Experiences of COVID-19 Vaccine Side-Effects Among Healthcare Workers in Southern Ethiopia: A Cross-Sectional Study.

Authors:  Bewunetu Zewude; Tewodros Habtegiorgis; Ashenafi Hizkeal; Tamirat Dela; Getahun Siraw
Journal:  Pragmat Obs Res       Date:  2021-12-16

5.  Pre-pandemic cognitive function and COVID-19 vaccine hesitancy: cohort study.

Authors:  G David Batty; Ian J Deary; Chloe Fawns-Ritchie; Catharine R Gale; Drew Altschul
Journal:  Brain Behav Immun       Date:  2021-05-20       Impact factor: 7.217

6.  Pre-pandemic mental and physical health as predictors of COVID-19 vaccine hesitancy: evidence from a UK-wide cohort study.

Authors:  G David Batty; Ian J Deary; Drew Altschul
Journal:  medRxiv       Date:  2021-04-30

7.  COVID-19 Vaccine Acceptability Among Clients and Staff of Homeless Shelters in Detroit, Michigan, February 2021.

Authors:  Ashley A Meehan; Michael Yeh; Annette Gardner; Tiera L DeFoe; Alberto Garcia; Patrick Vander Kelen; Martha P Montgomery; Ashley E Tippins; Andrea E Carmichael; Rachael Gibbs Chw; Hayat Caidi; Emily Mosites; Najibah Rehman
Journal:  Health Promot Pract       Date:  2021-10-23

8.  Medicare beneficiaries' plans for the COVID-19 vaccine in Fall 2020, and why some planned to decline.

Authors:  Louisa W Holaday; Lilanthi Balasuriya; Brita Roy; Joseph S Ross; Carol R Oladele
Journal:  J Am Geriatr Soc       Date:  2021-05-27       Impact factor: 7.538

9.  Attitudes towards COVID-19 Vaccination among Hospital Staff-Understanding What Matters to Hesitant People.

Authors:  Anne Spinewine; Catherine Pétein; Perrine Evrard; Christelle Vastrade; Christine Laurent; Bénédicte Delaere; Séverine Henrard
Journal:  Vaccines (Basel)       Date:  2021-05-06

Review 10.  HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies.

Authors:  Ronnie M Gravett; Jeanne M Marrazzo
Journal:  Curr HIV/AIDS Rep       Date:  2021-06-08       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.